+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Saizen"

From
Human Growth Hormone Market Report 2025 - Product Thumbnail Image

Human Growth Hormone Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Saizen is a brand of recombinant human growth hormone (rhGH) used to treat endocrine and metabolic disorders. It is a synthetic version of the naturally occurring hormone produced in the body, and is used to treat growth failure in children and adults. Saizen is also used to treat adults with growth hormone deficiency, a condition in which the body does not produce enough growth hormone. It is also used to treat short stature associated with Turner syndrome, Prader-Willi syndrome, and chronic renal insufficiency. Saizen is administered via subcutaneous injection, and is available in a variety of dosage forms, including pre-filled syringes, cartridges, and vials. It is also available in a variety of concentrations, including 5 mg, 8.8 mg, and 12 mg. The Saizen market is highly competitive, with a number of companies offering products in this space. These include Merck KGaA, Pfizer, Novo Nordisk, Eli Lilly, and Sandoz. Show Less Read more